-
2081
A 22 Billion M⊙ Black Hole in Holmberg 15A with Keck KCWI Spectroscopy and Triaxial Orbit Modeling
Published 2025-01-01Get full text
Article -
2082
Constructing age-structured matrix population models for all fishes
Published 2025-01-01Get full text
Article -
2083
-
2084
Mesenchymal Hippo signaling regulates intestinal homeostasis in adult mice
Published 2025-02-01Get full text
Article -
2085
Interface effects in the phase determination of Hf0.5Zr0.5O2 epitaxial thin films
Published 2025-01-01Get full text
Article -
2086
-
2087
One-Year Outcomes in Subjects Developing Macular Neovascularization While Undergoing Avacincaptad Pegol Therapy for Geographic Atrophy
Published 2025-01-01“…Ryan B Rush,1– 3 Westin Klein,1 Sloan W Rush,1,2 Robert Reinauer4 1Department of Ophthalmology, Panhandle Eye Group, Amarillo, TX, USA; 2Department of Surgery, Texas Tech University Health Science Center, Amarillo, TX, USA; 3Department of Ophthalmology, Southwest Retina Specialists, Amarillo, TX, USA; 4Department of Ophthalmology, New Vision Eye Center, Vero Beach, FL, USACorrespondence: Ryan B Rush, Southwest Retina Specialists, 7411 Wallace Blvd, Amarillo, TX, 79106, USA, Tel +1806 351 1870, Email ryan.rush.md@gmail.comPurpose: To assess the 12-month outcomes in subjects developing macular neovascularization (MNV) during intravitreal avacincaptad pegol (IVA) treatment for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).Methods: This research was conducted as a case-controlled, retrospective study of AMD subjects undergoing IVA treatment for GA from two private practice institutions. …”
Get full text
Article -
2088
-
2089
Propranolol for Treatment of Infantile Hemangioma: Efficacy and Effect on Pediatric Growth and Development
Published 2021-01-01Get full text
Article -
2090
-
2091
Aberrant heterochromatin silences immune response genes in chronic lymphocytic leukemia
Published 2025-02-01Get full text
Article -
2092
-
2093
Hepatitis due to Coxsackie A virus in an adult: a case report
Published 2025-02-01Get full text
Article -
2094
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
Published 2025-01-01Get full text
Article -
2095
3D Point Cloud from Millimeter-wave Radar for Human Action Recognition: Dataset and Method
Published 2025-02-01“…Data collection is conducted using Texas Instruments (TI)’s IWR1443-ISK and Vayyar’s vBlu radio imaging module, covering 12 common human actions, including walking, waving, standing, and falling. …”
Get full text
Article -
2096
-
2097
Instagram Versus Reality: Who Are Actually Plastic Surgeons?
Published 2025-01-01Get full text
Article -
2098
-
2099
Evolution of Magnetohydrodynamic Turbulence in the Expanding Solar Wind: Residual Energy and Intermittency
Published 2025-01-01Get full text
Article -
2100
Latest Advancements in Transcutaneous Electrical Nerve Stimulation (TENS) and Electronic Muscle Stimulation (EMS): Revisiting an Established Therapy with New Possibilities
Published 2025-01-01“…Department of Pain Medicine, San Diego, CA, USA; 3UCLA David Geffen School of Medicine/VA, Los Angeles, CA, 90095, USA; 4Timothy Growth, Pain Management and Chiropractic Care, Smithtown, NY, USA; 5North Texas Orthopedics and Spine Center, Grapevine, TX, 76051, USA; 6University of Wisconsin School of Medicine and Public Health, Health Sciences Learning Center, Madison, WI, 53705, USACorrespondence: Maja Green, Chief Scientific Officer, NXTSTIM Inc., Department of Pain Medicine, 5362 Sweetwater Trails, San Diego, CA, 92130, USA, Email mgreen@nxtstim.comAbstract: Transcutaneous Electrical Nerve Stimulation (TENS) and Electronic Muscle Stimulation (EMS) are non-invasive therapies widely used for pain relief and neuromuscular adaptation. …”
Get full text
Article